1. Clinical Resistance to Alkylations: Status and Perspectives
2. Role of Nonhomologous End-Joining and Recombinant DNA Repair in Resistanct to Nitrogen Mustard and DNA Crosslinking Agents
3. Repair of DNA Interstrand Crosslinks Produced by Cancer Chemotherapeutic Drugs
4. Chemosensitization to Platinum Based Anticancer Drugs: Current Trends and Future Prospects
5. Regulation of DNA Repair and Apoptosis by p53 and Its Impact on Alkylating Drug Resistance of Tumor Cells
6. Stress-Activated Signal Transduction Pathways in DNA Damage Response: Implications for Repair, Arrest and Therapeutic Interventions
7. Overcoming Resistance to Alkylating Agents by Inhibitors of O6-Alkylguanine-DNA Alkyltransferase
8. Cellular Protection Against the Antitumor Drug Bleomycin
9. Potential Role of PARP Inhibitors in Cancer Treatment and Cell Death
10. Relationship Among DNA Repair Genes, Cellular Radiosensitivity, and the Response of Tumors and Normal Tissue to Radiotherapy